TY - JOUR
T1 - Detection of Longitudinal Visual Field Progression in Glaucoma Using Machine Learning
AU - Yousefi, Siamak
AU - Kiwaki, Taichi
AU - Zheng, Yuhui
AU - Sugiura, Hiroki
AU - Asaoka, Ryo
AU - Murata, Hiroshi
AU - Lemij, Hans
AU - Yamanishi, Kenji
N1 - Copyright © 2018 Elsevier Inc. All rights reserved.
PY - 2018/9
Y1 - 2018/9
N2 - PURPOSE: Global indices of standard automated perimerty are insensitive to localized losses, while point-wise indices are sensitive but highly variable. Region-wise indices sit in between. This study introduces a machine learning-based index for glaucoma progression detection that outperforms global, region-wise, and point-wise indices.DESIGN: Development and comparison of a prognostic index.METHOD: Visual fields from 2085 eyes of 1214 subjects were used to identify glaucoma progression patterns using machine learning. Visual fields from 133 eyes of 71 glaucoma patients were collected 10 times over 10 weeks to provide a no-change, test-retest dataset. The parameters of all methods were identified using visual field sequences in the test-retest dataset to meet fixed 95% specificity. An independent dataset of 270 eyes of 136 glaucoma patients and survival analysis were used to compare methods.RESULTS: The time to detect progression in 25% of the eyes in the longitudinal dataset using global mean deviation (MD) was 5.2 (95% confidence interval, 4.1-6.5) years; 4.5 (4.0-5.5) years using region-wise, 3.9 (3.5-4.6) years using point-wise, and 3.5 (3.1-4.0) years using machine learning analysis. The time until 25% of eyes showed subsequently confirmed progression after 2 additional visits were included were 6.6 (5.6-7.4) years, 5.7 (4.8-6.7) years, 5.6 (4.7-6.5) years, and 5.1 (4.5-6.0) years for global, region-wise, point-wise, and machine learning analyses, respectively.CONCLUSIONS: Machine learning analysis detects progressing eyes earlier than other methods consistently, with or without confirmation visits. In particular, machine learning detects more slowly progressing eyes than other methods.
AB - PURPOSE: Global indices of standard automated perimerty are insensitive to localized losses, while point-wise indices are sensitive but highly variable. Region-wise indices sit in between. This study introduces a machine learning-based index for glaucoma progression detection that outperforms global, region-wise, and point-wise indices.DESIGN: Development and comparison of a prognostic index.METHOD: Visual fields from 2085 eyes of 1214 subjects were used to identify glaucoma progression patterns using machine learning. Visual fields from 133 eyes of 71 glaucoma patients were collected 10 times over 10 weeks to provide a no-change, test-retest dataset. The parameters of all methods were identified using visual field sequences in the test-retest dataset to meet fixed 95% specificity. An independent dataset of 270 eyes of 136 glaucoma patients and survival analysis were used to compare methods.RESULTS: The time to detect progression in 25% of the eyes in the longitudinal dataset using global mean deviation (MD) was 5.2 (95% confidence interval, 4.1-6.5) years; 4.5 (4.0-5.5) years using region-wise, 3.9 (3.5-4.6) years using point-wise, and 3.5 (3.1-4.0) years using machine learning analysis. The time until 25% of eyes showed subsequently confirmed progression after 2 additional visits were included were 6.6 (5.6-7.4) years, 5.7 (4.8-6.7) years, 5.6 (4.7-6.5) years, and 5.1 (4.5-6.0) years for global, region-wise, point-wise, and machine learning analyses, respectively.CONCLUSIONS: Machine learning analysis detects progressing eyes earlier than other methods consistently, with or without confirmation visits. In particular, machine learning detects more slowly progressing eyes than other methods.
KW - Aged
KW - Cross-Sectional Studies
KW - Diagnosis, Computer-Assisted
KW - Disease Progression
KW - Female
KW - Follow-Up Studies
KW - Glaucoma, Open-Angle/diagnosis
KW - Gonioscopy
KW - Humans
KW - Intraocular Pressure/physiology
KW - Machine Learning
KW - Male
KW - Middle Aged
KW - Tonometry, Ocular
KW - Vision Disorders/diagnosis
KW - Visual Field Tests
KW - Visual Fields/physiology
U2 - 10.1016/j.ajo.2018.06.007
DO - 10.1016/j.ajo.2018.06.007
M3 - Article
C2 - 29920226
SN - 0002-9394
VL - 193
SP - 71
EP - 79
JO - American Journal of Ophthalmology
JF - American Journal of Ophthalmology
ER -